US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Mustang Bio Inc (MBIO)
Mustang Bio Inc (MBIO) ニュース

MBIO

Mustang Bio (MBIO)

Mustang Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MBIO

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	19 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBIO	Mustang Bio Inc
2024/05/03	05 : 01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $4 Million Public Offering	NASDAQ:MBIO	Mustang Bio Inc
2024/04/30	09 : 00	GlobeNewswire Inc.	Mustang Bio Announces Pricing of $4 Million Public Offering	NASDAQ:MBIO	Mustang Bio Inc
2024/03/28	22 : 00	GlobeNewswire Inc.	Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05 : 05	GlobeNewswire Inc.	Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MBIO	Mustang Bio Inc
2024/03/07	21 : 30	GlobeNewswire Inc.	Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma	NASDAQ:MBIO	Mustang Bio Inc
2024/02/15	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/01/26	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/01/11	22 : 30	GlobeNewswire Inc.	Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference	NASDAQ:MBIO	Mustang Bio Inc
2024/01/05	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/12/20	06 : 06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2023/12/12	11 : 52	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2023/12/11	22 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/12/11	22 : 30	GlobeNewswire Inc.	Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting	NASDAQ:MBIO	Mustang Bio Inc
2023/11/15	06 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/11/15	06 : 05	GlobeNewswire Inc.	Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:MBIO	Mustang Bio Inc
2023/11/04	04 : 22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:MBIO	Mustang Bio Inc
2023/11/03	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/11/02	22 : 28	GlobeNewswire Inc.	Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:MBIO	Mustang Bio Inc
2023/10/31	03 : 57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/10/31	03 : 15	GlobeNewswire Inc.	Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2023/10/30	23 : 30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MBIO	Mustang Bio Inc
2023/10/27	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/10/27	01 : 30	GlobeNewswire Inc.	Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2023/10/26	22 : 00	GlobeNewswire Inc.	Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma	NASDAQ:MBIO	Mustang Bio Inc
2023/10/05	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/08/16	21 : 56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/08/15	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc

Showing the most relevant articles for your search:NASDAQ:MBIO

1 2 3 4 5 6 7 8 次へ >>

PowerShares Variable Rat...

Alterity Therapeutics

First National Financial

Collins Foods Ltd Newmar... (PK)

Amundi Luxembourg SA LU

Champion Technology (PK)

Pebblebrook Hotel

Vontobel Financial Produ...

MGX Minerals (CE)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約